-
公开(公告)号:US5616473A
公开(公告)日:1997-04-01
申请号:US287022
申请日:1994-08-08
申请人: Roberta L. Farrell , Paul Gelep , Algis Anilionis , Kashayar Javaherian , Theodore E. Maione , James Rusche , Bruce A. Sadownick , Jennifer A. Jackson
发明人: Roberta L. Farrell , Paul Gelep , Algis Anilionis , Kashayar Javaherian , Theodore E. Maione , James Rusche , Bruce A. Sadownick , Jennifer A. Jackson
IPC分类号: C12N9/04 , C08H20060101 , C08L20060101 , C12N20060101 , C12N1/16 , C12N1/18 , C12N1/19 , C12N1/20 , C12N9/00 , C12N9/08 , C12N15/09 , C12N15/29 , C12P20060101 , C12R1/19 , C12R1/865 , C07H21/04 , C12N15/31 , C12N15/52 , C12N15/81
CPC分类号: C12N9/0065
摘要: The gene encoding the ligninase rLDM.TM. 6 has been cloned and expressed. The ligninases produced via the processes disclosed herein are useful to degrade or modify lignin in pulp operations.
摘要翻译: 已经克隆并表达了编码木质素酶rLDM TM 6的基因。 通过本文公开的方法生产的木质素酶可用于在纸浆操作中降解或修饰木质素。
-
公开(公告)号:US5482923A
公开(公告)日:1996-01-09
申请号:US48812
申请日:1993-04-16
申请人: Theodore E. Maione
发明人: Theodore E. Maione
CPC分类号: A61K38/195
摘要: Circulating heparin in a mammal may be neutralized without substantial depletion of platelets or leukocytes by administering to the mammal a heparin neutralizing amount of a purified heparin binding fragment of PF4 or of recombinant PF4.
摘要翻译: 通过向哺乳动物施用肝素中和量的PF4或重组PF4的纯化肝素结合片段,可以中和哺乳动物中的循环肝素,而不会明显损耗血小板或白细胞。
-
公开(公告)号:US20110190214A1
公开(公告)日:2011-08-04
申请号:US12744859
申请日:2008-12-15
申请人: Theodore E. Maione
发明人: Theodore E. Maione
CPC分类号: C07K5/1016 , A61K38/00 , C07K5/10
摘要: The subject invention provides advantageous new salts of mu-opiate receptor peptides. These salts have been found to have excellent properties in terms of their crystal structure, stability, solubility, lack of impurities and/or the ability to be produced, with these advantageous properties, in amounts sufficient for the production of therapeutic compositions.
摘要翻译: 本发明提供了有利的mu-阿片受体肽的新盐。 已经发现,这些盐在它们的晶体结构,稳定性,溶解性,缺乏杂质和/或生产能力方面具有优异的性能,具有这些有利的性质,其用量足以制备治疗组合物。
-
公开(公告)号:US20110287040A1
公开(公告)日:2011-11-24
申请号:US13113392
申请日:2011-05-23
IPC分类号: A61K39/00 , A61P11/06 , A61P31/04 , A61P37/08 , A61P19/08 , A61P25/06 , A61P17/00 , A61P37/00 , A61K38/07 , A61P1/00 , A61P17/02 , A61P17/06 , A61P5/00 , A61P19/02
CPC分类号: A61K38/07
摘要: The subject invention pertains to peptides and salts thereof that are useful as anti-inflammatory agents and to compositions containing such peptides and salts as active ingredients. Specifically exemplified herein are endomorphin-1 peptide (EM-1), analogs and salts thereof, and uses for modulation of calcitonin gene-related peptide (CGRP) production and/or substance P (SP) and for treatment of inflammation, particularly neurogenic inflammation.
摘要翻译: 本发明涉及可用作抗炎剂的肽及其盐,以及含有这些肽和盐作为活性成分的组合物。 本文具体示例的是内啡肽-1(EM-1),其类似物和盐,以及用于调节降钙素基因相关肽(CGRP)产生和/或物质P(SP)和用于治疗炎症,特别是神经源性炎症的用途 。
-
公开(公告)号:US20110065648A1
公开(公告)日:2011-03-17
申请号:US12559994
申请日:2009-09-15
申请人: Theodore E. Maione
发明人: Theodore E. Maione
CPC分类号: C07K5/126 , A61K9/08 , A61K38/00 , C07K5/1016
摘要: The subject invention provides advantageous new salts of mu-opiate receptor peptides. These salts have been found to have excellent properties in terms of their activity.
摘要翻译: 本发明提供了有利的mu-阿片受体肽的新盐。 已经发现这些盐在其活性方面具有优异的性质。
-
公开(公告)号:US5800820A
公开(公告)日:1998-09-01
申请号:US456132
申请日:1995-05-31
申请人: Theodore E. Maione
发明人: Theodore E. Maione
CPC分类号: C07K14/522
摘要: The subject invention pertains to compositions and methods of treatment of angiogenesis using PF4 and peptide fragments thereof.
摘要翻译: 本发明涉及使用PF4及其肽片段治疗血管发生的组合物和方法。
-
公开(公告)号:US5204321A
公开(公告)日:1993-04-20
申请号:US902509
申请日:1992-06-23
IPC分类号: A61K38/19
CPC分类号: A61K38/195
摘要: Circulating heparin in a mammal may be neutralized without substantial depletion of platelets or leukocytes by administering to the mammal a heparin neutralizing amount of purified PF4 or rPF4 or a heparin neutralizing fragment thereof.
摘要翻译: 通过向哺乳动物施用肝素中和量的纯化的PF4或rPF4或其肝素中和片段,哺乳动物中的循环肝素可被中和而不会明显损耗血小板或白细胞。
-
公开(公告)号:US5759547A
公开(公告)日:1998-06-02
申请号:US473587
申请日:1995-06-07
申请人: Theodore E. Maione
发明人: Theodore E. Maione
IPC分类号: A61K38/00 , A61K38/19 , C07K14/52 , A61K39/36 , C07K14/745
CPC分类号: C07K14/522
摘要: The subject invention pertain to methods of treating Kaposi's Sarcoma and ocular neovascularization using rPF4 and angiogenesis-inhibiting fragments of rPF4.
摘要翻译: 本发明涉及使用rPF4和rPF4的血管生成抑制片段治疗卡波西肉瘤和眼新生血管形成的方法。
-
公开(公告)号:US5077394A
公开(公告)日:1991-12-31
申请号:US455663
申请日:1989-12-21
申请人: David H. Dolphin , Taku Nakano , Thomas K. Kirk , Tilak P. Wijesekera , Roberta L. Farrell , Theodore E. Maione
发明人: David H. Dolphin , Taku Nakano , Thomas K. Kirk , Tilak P. Wijesekera , Roberta L. Farrell , Theodore E. Maione
IPC分类号: B01J31/18 , C07C29/50 , C07C45/28 , C07C45/29 , C07C45/30 , C07D301/02 , C07D301/03 , C07D487/22 , D21C3/00
CPC分类号: D21C3/003 , B01J31/1815 , C07C29/50 , C07C45/28 , C07C45/29 , C07C45/294 , C07C45/30 , C07D301/02 , C08H6/00 , B01J2531/025 , B01J2531/842 , C07C2101/14
摘要: Disclosed are tetraphenyl porphyrins which are beta-substituted by fluoro or chloro and/or bear electronegative substituents on the phenyl including one or two water solubilizing substituents. The new porphorins are particularly suitable as catalysts in a variety of oxidative reactions and methods.
摘要翻译: 公开的是在苯基上被氟或氯和/或带有负电负离子取代基的四苯基卟啉,包括一个或两个水溶性取代基。 新的porphorins特别适用于各种氧化反应和方法中的催化剂。
-
公开(公告)号:US4892941A
公开(公告)日:1990-01-09
申请号:US181859
申请日:1988-04-15
申请人: David H. Dolphin , Taku Nakano , Thomas K. Kirk , Tilak P. Wijesekera , Roberta L. Farrell , Theodore E. Maione
发明人: David H. Dolphin , Taku Nakano , Thomas K. Kirk , Tilak P. Wijesekera , Roberta L. Farrell , Theodore E. Maione
IPC分类号: B01J31/18 , C07C29/50 , C07C45/28 , C07C45/29 , C07C45/30 , C07D301/02 , C07D487/22 , D21C3/00
CPC分类号: D21C3/003 , B01J31/1815 , C07C29/50 , C07C45/28 , C07C45/29 , C07C45/294 , C07C45/30 , C07D301/02 , C08H6/00 , B01J2531/025 , B01J2531/842 , B01J2531/96 , C07C2101/14 , C07C2101/16
摘要: Disclosed are tetraphenyl porphyrins which are beta-substituted by fluoro or chloro and/or bear electronegative substituents on the phenyl including one or two water solubilizing substituents. The new porphorins are particularly suitable as catalysts in a variety of oxidative reactions and methods.
摘要翻译: 公开的是在苯基上被氟或氯和/或带有负电负离子取代基的四苯基卟啉,包括一个或两个水溶性取代基。 新的porphorins特别适用于各种氧化反应和方法中的催化剂。
-
-
-
-
-
-
-
-
-